J
Josemir W. Sander
Researcher at UCL Institute of Neurology
Publications - 705
Citations - 44517
Josemir W. Sander is an academic researcher from UCL Institute of Neurology. The author has contributed to research in topics: Epilepsy & Population. The author has an hindex of 106, co-authored 680 publications receiving 39038 citations. Previous affiliations of Josemir W. Sander include University of Cincinnati & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.
TL;DR: A follow up audit of patients recruited from 1987 to 1989 into two uncontrolled open label clinical studies of lamotrigine and vigabatrin finds no change in the long term prognosis of refractory epilepsy as measured by mortality and freedom from seizures.
Journal ArticleDOI
Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy
TL;DR: Oral ucb L059 may be useful in the treatment of refractory partial epilepsy, and is associated with a significant reduction in partial seizures as compared with baseline or placebo.
Journal ArticleDOI
The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11–14 years
TL;DR: Out of 30 000 patients with newly diagnosed epilepsy every year in the United Kingdom, about 6000 have inadequate seizure control in the long term, and only two thirds of these patients with frequent seizures are likely to switch medication to try and achieve better seizure control.
Journal ArticleDOI
The impact of levetiracetam on challenging behavior
TL;DR: An observational longitudinal design was employed to evaluate whether treatment with the antiepileptic drug levetiracetam (LEV) adversely impacts behavior in people with intellectual disabilities and/or acquired brain damage.
Journal ArticleDOI
The natural history of epilepsy in the era of new antiepileptic drugs and surgical treatment.
TL;DR: The factors influencing prognosis of epilepsy in this era of antiepileptic drugs and surgical treatment are reviewed.